Mackenzie Maximum Diversification All World Developed ex North (TSX: MXU)
Canada
· Delayed Price · Currency is CAD
22.63
-0.10 (-0.44%)
May 16, 2024, 1:28 PM EDT
4.19% (1Y)
Assets | 24.78M |
Expense Ratio | 0.76% |
PE Ratio | 16.92 |
Dividend (ttm) | 0.22 |
Dividend Yield | 0.97% |
Ex-Dividend Date | Jun 19, 2023 |
Payout Frequency | n/a |
Payout Ratio | 16.37% |
1-Year Return | +3.76% |
Volume | 200 |
Open | 22.63 |
Previous Close | 22.73 |
Day's Range | 22.63 - 22.63 |
52-Week Low | 19.79 |
52-Week High | 22.73 |
Beta | 0.82 |
Holdings | 606 |
Inception Date | Sep 7, 2016 |
About MXU
Mackenzie Maximum Diversification All World Developed ex North (MXU) is an exchange-traded fund that trades on the Toronto Stock Exchange in Canada. It tracks an index of developed-country equity securities, excluding the US and Canada, filtered through a proprietary ESG criteria, and optimized to maximize a measure of diversification.
Asset Class Equity
Category Total Market
Stock Exchange TSX
Ticker Symbol MXU
Provider Mackenzie
Index Tracked TOBAM Maximum Diversification All World Developed ex Northe America Index - USD
Performance
MXU had a total return of 3.76% in the past year. Since the fund's inception, the average annual return has been 1.46%, including dividends.
Top 10 Holdings
15.15% of assetsName | Symbol | Weight |
---|---|---|
Teva Pharmaceutical Industries Ltd | TEVA.TA | 1.86% |
UCB SA | UCB.BR | 1.63% |
Cash | n/a | 1.59% |
Novo Nordisk A/S Class B | NOVO B.CO | 1.55% |
AstraZeneca PLC | AZN.L | 1.54% |
Novartis AG Registered Shares | NOVN.SW | 1.46% |
Sanofi SA | SAN.PA | 1.45% |
Nestle SA | NESN.SW | 1.45% |
argenx SE | ARGX.BR | 1.38% |
Daiichi Sankyo Co Ltd | 4568.T | 1.25% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Jun 19, 2023 | 0.21852 CAD | Jun 27, 2023 |
Mar 20, 2023 | 0.00729 CAD | Mar 28, 2023 |
Dec 19, 2022 | 0.1415 CAD | Dec 29, 2022 |
Sep 19, 2022 | 0.09214 CAD | Sep 27, 2022 |
Jun 20, 2022 | 0.18648 CAD | Jun 28, 2022 |
Mar 21, 2022 | 0.00956 CAD | Mar 29, 2022 |